expanding the nsclc armamentarium: impower131
Published 5 years ago • 23 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
2:54
advanced squamous nsclc: the impower131 study
-
1:42
dr. nadler discusses the impower131 study in squamous nsclc
-
2:11
dr. jotte on the impower131 findings in squamous nsclc
-
2:09
dr. subramanian on the impower131 trial in squamous nsclc
-
4:12
nondriver nsclc: adding pembrolizumab to platinum-based chemotherapy
-
9:15
chemo/immunotherapy in advanced squamous nsclc: what is the impact of impower131? (bmic-026)
-
3:29
squamous cell frontline therapy: impower 131, keynote-407
-
8:10
impower131: role for carbo/nab-paclitaxel/atezolizumab combo for adv. squamous nsclc? (bmic-041)
-
2:44
pembrolizumab and chemotherapy in advanced nsclc
-
3:04
keynote-024 update: pembrolizumab vs platinum-based chemotherapy in nsclc
-
0:32
nsclc workflows: tumor enrichment
-
4:23
management of patients with pdl1-high advanced nsclc
-
3:28
advanced-stage nondriver nsclc: impower150 trial
-
3:18
looking at the impower data in nsclc
-
1:53
dr. spigel on pembrolizumab/chemo combo in first-line nsclc
-
8:52
immunotherapy chemotherapy in nonsquamous nsclc
-
7:06
chemotherapy considerations in locally advanced nsclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc